{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:15:16Z","timestamp":1790396116558,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jinf.2020.12.003","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T11:33:55Z","timestamp":1607081635000},"page":"227-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk factors and outcomes associated with the carriage of tigecycline- and vancomycin-resistant"],"prefix":"10.1016","volume":"82","author":[{"given":"Johanna","family":"Kessel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matas","family":"Griskaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Lehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Serve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zacharowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zeuzem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.G.T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Wichelhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkhard A.J.","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hogardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2020.12.003_bib0001","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S1473-3099(01)00145-1","article-title":"Vancomycin-resistant enterococci: why are they here, and where do they come from?","volume":"1","author":"Bonten","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2020.12.003_bib0002","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13756-018-0353-x","article-title":"Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance","volume":"7","author":"Remschmidt","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jinf.2020.12.003_bib0003","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/jac\/dkaa041","article-title":"Whole-genome analysis of vancomycin-resistant Enterococcus faecium causing nosocomial outbreaks suggests the occurrence of few endemic clonal lineages in Bavaria, Germany","volume":"75","author":"Eisenberger","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2020.12.003_bib0004","unstructured":"ECDC. SURVEILLANCE REPORT. Surveillance of antimicrobial resistance in Europe 2018 [Internet]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/surveillance-antimicrobial-resistance-Europe-2018.pdf."},{"key":"10.1016\/j.jinf.2020.12.003_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drup.2018.10.002","article-title":"Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: towards a common nomenclature","volume":"40","author":"Bender","year":"2018","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jinf.2020.12.003_bib0006","unstructured":"ATLAS Database. ATLAS antimicrobial testing leadership and surveillance: antimicrobial testing leadership and surveillance [Internet]. Available from: https:\/\/atlas-surveillance.com."},{"key":"10.1016\/j.jinf.2020.12.003_bib0007","doi-asserted-by":"crossref","first-page":"ofy185","DOI":"10.1093\/ofid\/ofy185","article-title":"Risk factors and outcomes associated with acquisition of daptomycin and linezolid-nonsusceptible vancomycin-resistant Enterococcus","volume":"5","author":"Greene","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jinf.2020.12.003_bib0008","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1080\/10428194.2017.1312665","article-title":"Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes","volume":"58","author":"Herc","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jinf.2020.12.003_bib0009","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1089\/mdr.2019.0346","article-title":"A nosocomial cluster of tigecycline- and vancomycin-resistant Enterococcus faecium Isolates and the Impact of rpsJ and tet(M) mutations on tigecycline resistance","volume":"26","author":"Bender","year":"2020","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jinf.2020.12.003_bib0010","unstructured":"Robert Koch-Institut. Epidemiologisches bulletin des Robert Koch-Instituts Ausgabe 46\/2017 [Internet]. Available from: https:\/\/edoc.rki.de\/bitstream\/handle\/176904\/2880\/28Hafx6gkebU.pdf?sequence=1&isAllowed=y."},{"key":"10.1016\/j.jinf.2020.12.003_bib0011","unstructured":"Robert Koch-Institut. Epidemiologisches bulletin des Robert Koch-Instituts Ausgabe 35\/2019 [Internet]. Available from: https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2019\/Ausgaben\/35_19.pdf?__blob=publicationFile."},{"key":"10.1016\/j.jinf.2020.12.003_bib0012","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1128\/JCM.01946-15","article-title":"Core genome multilocus sequence typing scheme for high- resolution typing of Enterococcus faecium","volume":"53","author":"Been","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2020.12.003_bib0013","unstructured":"KRINKO. Hygienema\u00dfnahmen zur Pr\u00e4vention der Infektion durch Enterokokken mit speziellen Antibiotikaresistenzen [Internet]. Available from: https:\/\/www.rki.de\/DE\/Content\/Infekt\/Krankenhaushygiene\/Kommission\/Downloads\/Enterokokken_Rili.pdf?__blob=publicationFile."},{"key":"10.1016\/j.jinf.2020.12.003_bib0014","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13756-019-0573-8","article-title":"Near-ubiquitous presence of a vancomycin-resistant Enterococcus faecium ST117\/CT71\/vanB -clone in the Rhine-main metropolitan area of Germany","volume":"8","author":"Falgenhauer","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jinf.2020.12.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkaa271","article-title":"Vancomycin-resistant Enterococcus faecium colonizing patients on hospital admission in Germany: prevalence and molecular epidemiology","author":"Xanthopoulou","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2020.12.003_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100732","article-title":"Thirty years of VRE in Germany - \"expect the unexpected\": the view from the national reference centre for staphylococci and enterococci","volume":"53","author":"Werner","year":"2020","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jinf.2020.12.003_bib0017","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1017\/ice.2017.248","article-title":"Vancomycin-resistant enterococci (VRE) in the intensive care unit in a nonoutbreak setting: identification of potential reservoirs and epidemiological associations between patient and environmental VRE","volume":"39","author":"McDermott","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2020.12.003_bib0018","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1017\/ice.2018.29","article-title":"Defining the role of the environment in the emergence and persistence of vanA vancomycin-resistant Enterococcus (VRE) in an intensive care unit: a molecular epidemiological study","volume":"39","author":"Lee","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2020.12.003_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235160","article-title":"Comprehensive integrated NGS-based surveillance and contact-network modeling unravels transmission dynamics of vancomycin-resistant enterococci in a high-risk population within a tertiary care hospital","volume":"15","author":"Neumann","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2020.12.003_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01978-18","article-title":"Expansion of vancomycin-resistant Enterococcus faecium in an academic tertiary hospital in southwest germany: a large-scale whole-genome-based outbreak investigation","volume":"63","author":"Liese","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2020.12.003_bib0021","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/AAC.49.1.438-440.2005","article-title":"Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice","volume":"49","author":"Pultz","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2020.12.003_bib0022","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/502408","article-title":"Vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice","volume":"25","author":"Stiefel","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2020.12.003_bib0023","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/AAC.02590-15","article-title":"Effect of fidaxomicin versus vancomycin on susceptibility to intestinal colonization with vancomycin-resistant enterococci and klebsiella pneumoniae in mice","volume":"60","author":"Deshpande","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2020.12.003_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02237-17","article-title":"Tapering courses of oral vancomycin induce persistent disruption of the microbiota that provide colonization resistance to clostridium difficile and vancomycin-resistant enterococci in mice","volume":"62","author":"Tomas","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2020.12.003_bib0025","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Taur","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.12.003_bib0026","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1017\/ice.2014.3","article-title":"Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia","volume":"36","author":"Ford","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2020.12.003_bib0027","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.05947-11","article-title":"Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection","volume":"56","author":"Ben-Ami","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2020.12.003_bib0028","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/tid.12612","article-title":"Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia","volume":"18","author":"Hefazi","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jinf.2020.12.003_bib0029","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00102-19","article-title":"Diversification and evolution of vancomycin-resistant Enterococcus faecium during intestinal domination","volume":"87","author":"Dubin","year":"2019","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2020.12.003_bib0030","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1128\/AAC.04296-14","article-title":"Effects of tigecycline and vancomycin administration on established clostridium difficile infection","volume":"59","author":"Theriot","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2020.12.003_bib0031","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2334-14-29","article-title":"Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin\/tazobactam matching","volume":"14","author":"Garneau","year":"2014","journal-title":"BMC Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320307635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320307635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:29:59Z","timestamp":1759008599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445320307635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0163445320307635"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2020.12.003","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and outcomes associated with the carriage of tigecycline- and vancomycin-resistant Enterococcus faecium","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2020.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}